Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2019-10, Vol.30, p.v431 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | v431 |
| container_title | Annals of oncology |
| container_volume | 30 |
| creator | Vergote, I.B. Copeland, L. Monk, B.J. Coleman, R.L. Cibula, D. Sehouli, J. Samartzis, E.P. Radoslaw, M. Martín, A González Korach, J. Salutari, V. Witteveen, P.O. O’Malley, D. |
| description | |
| doi_str_mv | 10.1093/annonc/mdz250.067 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz250_067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz250_067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1337-ed50a83ddcea216feaa18cf8d1875dcec62f50a9b7f05680f67aec0fafbdebfd3</originalsourceid><addsrcrecordid>eNotkM1OwkAUhWehiYg-gLtZ6qJwp2P_3BGC0ISAi-q2uczckUp_yEwB4Sl8ZIu4OsmXc87iY-xBwEBAIodY102thpU--QEMIIyuWA8SX3pRIJ9v2K1zXwAQJn7SYz_Zrmp2lreWsC3qT24KKrXjjz4A38xOT1x1X01VtFi3_FC0a34g2pRHvkVVdvSbSm4ay7fleb-rPEuucH_tZo-2wJorrBXZF_62Rkc8TVOeLhbLj1E28eRwspguM6_ZB8Bdu9PHO3ZtsHR0_5999v46ycYzb76cpuPR3FNCysgjHQDGUmtF6IvQEKKIlYm1iKOggyr0TddIVpGBIIzBhBGSAoNmpWlltOwzcflVtnHOksm3tqjQHnMB-VljftGYXzTmnUb5C_KAbX8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Vergote, I.B. ; Copeland, L. ; Monk, B.J. ; Coleman, R.L. ; Cibula, D. ; Sehouli, J. ; Samartzis, E.P. ; Radoslaw, M. ; Martín, A González ; Korach, J. ; Salutari, V. ; Witteveen, P.O. ; O’Malley, D.</creator><creatorcontrib>Vergote, I.B. ; Copeland, L. ; Monk, B.J. ; Coleman, R.L. ; Cibula, D. ; Sehouli, J. ; Samartzis, E.P. ; Radoslaw, M. ; Martín, A González ; Korach, J. ; Salutari, V. ; Witteveen, P.O. ; O’Malley, D.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz250.067</identifier><language>eng</language><ispartof>Annals of oncology, 2019-10, Vol.30, p.v431</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1337-ed50a83ddcea216feaa18cf8d1875dcec62f50a9b7f05680f67aec0fafbdebfd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Vergote, I.B.</creatorcontrib><creatorcontrib>Copeland, L.</creatorcontrib><creatorcontrib>Monk, B.J.</creatorcontrib><creatorcontrib>Coleman, R.L.</creatorcontrib><creatorcontrib>Cibula, D.</creatorcontrib><creatorcontrib>Sehouli, J.</creatorcontrib><creatorcontrib>Samartzis, E.P.</creatorcontrib><creatorcontrib>Radoslaw, M.</creatorcontrib><creatorcontrib>Martín, A González</creatorcontrib><creatorcontrib>Korach, J.</creatorcontrib><creatorcontrib>Salutari, V.</creatorcontrib><creatorcontrib>Witteveen, P.O.</creatorcontrib><creatorcontrib>O’Malley, D.</creatorcontrib><title>Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotkM1OwkAUhWehiYg-gLtZ6qJwp2P_3BGC0ISAi-q2uczckUp_yEwB4Sl8ZIu4OsmXc87iY-xBwEBAIodY102thpU--QEMIIyuWA8SX3pRIJ9v2K1zXwAQJn7SYz_Zrmp2lreWsC3qT24KKrXjjz4A38xOT1x1X01VtFi3_FC0a34g2pRHvkVVdvSbSm4ay7fleb-rPEuucH_tZo-2wJorrBXZF_62Rkc8TVOeLhbLj1E28eRwspguM6_ZB8Bdu9PHO3ZtsHR0_5999v46ycYzb76cpuPR3FNCysgjHQDGUmtF6IvQEKKIlYm1iKOggyr0TddIVpGBIIzBhBGSAoNmpWlltOwzcflVtnHOksm3tqjQHnMB-VljftGYXzTmnUb5C_KAbX8</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Vergote, I.B.</creator><creator>Copeland, L.</creator><creator>Monk, B.J.</creator><creator>Coleman, R.L.</creator><creator>Cibula, D.</creator><creator>Sehouli, J.</creator><creator>Samartzis, E.P.</creator><creator>Radoslaw, M.</creator><creator>Martín, A González</creator><creator>Korach, J.</creator><creator>Salutari, V.</creator><creator>Witteveen, P.O.</creator><creator>O’Malley, D.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201910</creationdate><title>Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study</title><author>Vergote, I.B. ; Copeland, L. ; Monk, B.J. ; Coleman, R.L. ; Cibula, D. ; Sehouli, J. ; Samartzis, E.P. ; Radoslaw, M. ; Martín, A González ; Korach, J. ; Salutari, V. ; Witteveen, P.O. ; O’Malley, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1337-ed50a83ddcea216feaa18cf8d1875dcec62f50a9b7f05680f67aec0fafbdebfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vergote, I.B.</creatorcontrib><creatorcontrib>Copeland, L.</creatorcontrib><creatorcontrib>Monk, B.J.</creatorcontrib><creatorcontrib>Coleman, R.L.</creatorcontrib><creatorcontrib>Cibula, D.</creatorcontrib><creatorcontrib>Sehouli, J.</creatorcontrib><creatorcontrib>Samartzis, E.P.</creatorcontrib><creatorcontrib>Radoslaw, M.</creatorcontrib><creatorcontrib>Martín, A González</creatorcontrib><creatorcontrib>Korach, J.</creatorcontrib><creatorcontrib>Salutari, V.</creatorcontrib><creatorcontrib>Witteveen, P.O.</creatorcontrib><creatorcontrib>O’Malley, D.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vergote, I.B.</au><au>Copeland, L.</au><au>Monk, B.J.</au><au>Coleman, R.L.</au><au>Cibula, D.</au><au>Sehouli, J.</au><au>Samartzis, E.P.</au><au>Radoslaw, M.</au><au>Martín, A González</au><au>Korach, J.</au><au>Salutari, V.</au><au>Witteveen, P.O.</au><au>O’Malley, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study</atitle><jtitle>Annals of oncology</jtitle><date>2019-10</date><risdate>2019</risdate><volume>30</volume><spage>v431</spage><pages>v431-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz250.067</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2019-10, Vol.30, p.v431 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdz250_067 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T07%3A17%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumour%20treating%20fields%20(200%20kHz)%20concomitant%20with%20weekly%20paclitaxel%20for%20platinum-resistant%20ovarian%20cancer:%20Phase%20III%20INNOVATE-3/ENGOT-ov50%20study&rft.jtitle=Annals%20of%20oncology&rft.au=Vergote,%20I.B.&rft.date=2019-10&rft.volume=30&rft.spage=v431&rft.pages=v431-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz250.067&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz250_067%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |